Aptorum Group (Aptorum Group) Change In Payables And Accrued Expense : $0.83 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Change In Payables And Accrued Expense?

Aptorum Group's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was $-0.41 Mil. It means Aptorum Group's Accounts Payable & Accrued Expense declined by $0.41 Mil from Dec. 2022 to Jun. 2023 .

Aptorum Group's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was $1.91 Mil. It means Aptorum Group's Accounts Payable & Accrued Expense increased by $1.91 Mil from Dec. 2021 to Dec. 2022 .

Aptorum Group Change In Payables And Accrued Expense Historical Data

The historical data trend for Aptorum Group's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Change In Payables And Accrued Expense Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.06

0.96

0.68

0.59

1.91

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial							0.73	-0.14	0.68	1.23	-0.41

Aptorum Group Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.83 Mil.

Aptorum Group Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.